Leht 1 alates 95 tulemused
BACKGROUND OF THE INVENTION
Rats, e.g., have particularly good memories and a relatively high intelligence quotient. They are able to connect the toxic effect of rapidly-acting poisons with the type and position of employed bait, and they warn other rats.
Rodenticides comprising anti-coagulating or
This application is a 371 of PCT/CN07/03526, filed Dec. 11, 2007, which claims priority to Chinese patent application 200610165756.7, filed Dec. 16, 2006.
FIELD OF INVENTION
This invention belongs to the area of biotechnology, and relates to structure and preparation of a kind of anticoagulant
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
The entire content of all above applications is incorporated herein by reference.
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent
SEQUENCE LISTING
The instant application contains a Sequence Listing (.txt file named Sequence_Listing, having a date of May 4, 2018 and 63,944 bytes in size) which has been submitted in ASCII format via EFS-Web and is incorporated by reference herein.
FIELD
This invention relates to modified serpin
FIELD
This invention relates to modified serpin molecules with altered specificity, in particular serpin molecules modified to have increased specificity for anticoagulant proteases, such as activated Protein C (APC).
BACKGROUND
Hemophilias are bleeding disorders, which are caused by a deficiency in
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/IB2008/000945, filed on Apr. 18, 2008, which claims the benefit of U.S. Provisional Application No. 60/907,875, filed on Apr. 20, 2007, the entire contents of which are herein
FIELD OF THE INVENTION
The invention relates to treatment and prevention of a certain form of shock, hypovolemic shock and related syndromes with substantially non-anticoagulant chemically modified heparinoids. The heparinoids preserve the function of heart, liver, kidney and gut, protect
FIELD OF THE INVENTION
The invention relates to treatment and prevention of a certain form of shock, hypovolemic shock and related syndromes with substantially non-anticoagulant chemically modified heparinoids. The heparinoids preserve the function of heart, liver, kidney and gut, protect
TECHNICAL FIELD
This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)